Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?

Abstract

Background The optimal management pathway for the dysfunctional right ventricular outflow tract (RVOT) is uncertain. We evaluated the long‐term outcomes and clinical impact of stent implantation for obstructed RVOTs in an era of rapidly progressing transcatheter pulmonary valve technology. Methods Retrospective review of 151 children with a biventricular repair who underwent stenting of obstructed RVOT between 1991 and 2017. Results RVOT stenting resulted in significant changes in peak right ventricle (RV)‐to‐pulmonary artery (PA) gradient (39.4 ± 17.1–14.9 ± 8.3; p < 0.001) and RV‐to‐aortic pressure ratio (0.78 ± 0.22–0.49 ± 0.13; p < 0.001). Subsequent percutaneous reinterventions in 51 children to palliate recurrent stenosis were similarly effective. Ninety‐nine (66%) children reached the primary outcome of subsequent pulmonary valve replacement (PVR). Freedom from PVR from the time of stent implantation was 91%, 51%, and 23% at 1, 5, and 10 years, respectively. Small balloon diameters for stent deployment were associated with shorter freedom from PVR. When additional children without stent palliation (with RV‐to‐PA conduits) were added to the stent cohort (total 506 children), the multistate analysis showed the longest freedom from PVR in those with stent palliation and subsequent catheter reintervention. Pulmonary regurgitation was well‐tolerated clinically. Indexed RV dimensions and function estimated by echocardiography remained stable at last follow up or before primary outcome. Conclusion Prolongation of conduit longevity with stent implant remains an important strategy to allow for somatic growth to optimize the risk‐benefit profile for subsequent surgical or transcatheter pulmonary valve replacement performed at an older age.

Abordagens contemporâneas no tratamento da estenose aórtica

“…O tratamento padrão-ouro para a EA é a substituição da valva aórtica por meio da cirurgia aberta convencional, que tem demonstrado excelentes resultados em termos de sobrevida e qualidade de vida em longo prazo (BAUMGARTNER H, et al, 2017). No entanto, essa abordagem cirúrgica invasiva pode não ser apropriada para todos os pacientes, especialmente aqueles com alto risco cirúrgico (KANG SL, et al, 2022).…”